The Food and Drug Administration (FDA) abruptly canceled a vaccine advisory meeting where members were slated to discuss influenza vaccine strains. The meeting was scheduled for March 13.
A personalized vaccine demonstrated the potential to induce long-lasting immune response among people with advanced kidney cancer, according to results of a phase 1 trial.All nine study participants — who had undergone surgery for stage III or stage IV clear cell renal cell carcinoma — remained cancer free approximately 3 years after treatment.
Trump administration officials have canceled a federal vaccine advisory committee meeting expected to be held next month that was intended to help select the makeup of next winter’s influenza ...